These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 8605723)
41. Think of oxalate when using ascorbate supplementation to optimize iron therapy in dialysis patients. Canavese C; Marangella M; Stratta P Nephrol Dial Transplant; 2008 Apr; 23(4):1463-4; author reply 1464. PubMed ID: 18029374 [No Abstract] [Full Text] [Related]
42. Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis. Shahapuni I; Esper NE; Opisiv R; Massy Z; Choukroun G; Garabedian M; Fournier A Nephrol Dial Transplant; 2008 Apr; 23(4):1456-7; author reply 1457-8. PubMed ID: 18039645 [No Abstract] [Full Text] [Related]
43. Obesity and elevated intraocular pressure. Korenfeld MS Ophthalmology; 1999 Jun; 106(6):1041. PubMed ID: 10366062 [No Abstract] [Full Text] [Related]
44. Impaired sympathetic response before intradialytic hypotension: a study based on spectral analysis of heart rate and pressure variability. Pelosi G; Emdin M; Carpeggiani C; Morales MA; Piacenti M; Dattolo P; Cerrai T; Macerata A; L'abbate A; Maggiore Q Clin Sci (Lond); 1999 Jan; 96(1):23-31. PubMed ID: 9857103 [TBL] [Abstract][Full Text] [Related]
45. Systemic inflammation is associated with pulmonary hypertension in patients undergoing haemodialysis. Yu TM; Chen YH; Hsu JY; Sun CS; Chuang YW; Chen CH; Wu MJ; Cheng CH; Shu KH Nephrol Dial Transplant; 2009 Jun; 24(6):1946-51. PubMed ID: 19164324 [TBL] [Abstract][Full Text] [Related]
46. Cardiac disease in chronic uremia: can it explain the reverse epidemiology of hypertension and survival in dialysis patients? Foley RN Semin Dial; 2004; 17(4):275-8. PubMed ID: 15250917 [TBL] [Abstract][Full Text] [Related]
52. The first 15 minutes of hemodialysis does not affect platelets. Komarnicki M; Kaźmierczak M; de Mezer-Dambek M Haematologia (Budap); 1996; 28(1):41-4. PubMed ID: 9283903 [TBL] [Abstract][Full Text] [Related]
53. Association of high-flux dialysers and bacterial contamination of dialysate-induced chronic release of cytokines in haemodialysis patients. Perez-Garcia R; Anaya F; Chisvert J; Valderrabano F Nephrol Dial Transplant; 1995 Nov; 10(11):2164-6. PubMed ID: 8643200 [No Abstract] [Full Text] [Related]
54. [Intraocular pressure in phacoemulsification]. Synek S; Synková M; Skorkovská S Cesk Slov Oftalmol; 2002 Jan; 58(1):46-50. PubMed ID: 11852555 [TBL] [Abstract][Full Text] [Related]
55. Malnutrition in the elderly patient on dialysis. Lacquaniti A; Bolignano D; Campo S; Perrone C; Donato V; Fazio MR; Buemi A; Sturiale A; Buemi M Ren Fail; 2009; 31(3):239-45. PubMed ID: 19288330 [TBL] [Abstract][Full Text] [Related]
56. Adequacy of treatment of uremia in the nineties. David S; Cambi V Contrib Nephrol; 1993; 103():1-9. PubMed ID: 8354052 [No Abstract] [Full Text] [Related]
57. Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia. Attman PO Nephrol Dial Transplant; 2006 Jun; 21(6):1738. PubMed ID: 16364986 [No Abstract] [Full Text] [Related]
58. Depression in dialysis patients: rubidium supplementation before other drugs and encouragement? Canavese C; DeCostanzi E; Branciforte L; Caropreso A; Nonnato A; Sabbioni E Kidney Int; 2001 Sep; 60(3):1201-2. PubMed ID: 11532118 [No Abstract] [Full Text] [Related]
59. [Functional characteristics of the lung in uremia. Changes as a result of dialysis]. Gómez Fernández P; Sánchez Agudo L; Calatrava JM; Miguel JL; Beberide JM; Selgas R; Sánchez Sicilia L Rev Clin Esp; 1982 Sep; 166(6):277-9. PubMed ID: 7178568 [No Abstract] [Full Text] [Related]
60. Interleukin/cytokine profiles in haemodialysis and in continuous peritoneal dialysis. Jacobs P; Glorieux G; Vanholder R Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V41-45. PubMed ID: 15284359 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]